Leishmaniasis is a widespread disease that causes 20,000 to 30,000 deaths annually,
making it a major health problem in endemic areas. Because of low-performance …

Cutaneous leishmaniasis (CL) is a global public health issue. Conventional treatments have
substantial costs, side effects, and parasite resistance. Due to easy application and …

Background Leishmaniasis is a destructive protozoan parasitic and vector-borne infection
characterized as a neglected tropical disease (NTD) that is currently endemic in more than …

Cutaneous leishmaniasis (CL) is a neglected tropical skin disease caused by the protozoan
genus Leishmania. The treatment is restricted to a handful number of drugs that exhibit toxic …

Leishmaniasis is a prevalent parasitic infection belonging to neglected tropical diseases. It is
caused by Leishmania protozoan parasites transmitted by sandflies and it is responsible for …

Background Cutaneous leishmaniasis (LC) is an infectious vector-borne disease caused by
parasites belonging to the genus Leishmania. Metallic nanoparticles (MNPs) have been …

Leishmaniasis is a neglected tropical disease that has a wide spectrum of clinical
manifestations, ranging from visceral to cutaneous, with millions of new cases and …

Toxoplasma gondii is a protozoan parasite that can cause severe and debilitating diseases,
especially in immunocompromised individuals. The available treatment is based on drugs …

Many efforts in these last years have dedicated in the development of new drugs due to an
increase of microbial organisms resistant to multiple antibiotics, and silver nanoparticles …

Background: We aimed to investigate the effect of miR-15a mimic and inhibitor of miR-155
expression on apoptosis induction in macrophages infected with Iranian strain of …